A(4-24)(F23A)H2 [416]
A(4-24)(F23A)H2
| SMILES | CC(C)CC(NC(=O)C(C)NC(=O)C(N)CO)C(=O)NC(C)C(=O)NC(CC(N)=O)C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CS)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C(=O)NCC(=O)NC(CS)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CS)C(=O)O)C(C)O)C(C)C |
| InChIKey | JPICFXXNKSFHNE-UHFFFAOYSA-N |
| Sequence | SALANKCCHVGCTKRSLARAC |
| HELM | PEPTIDE1{S.A.L.A.N.K.C.C.H.V.G.C.T.K.R.S.L.A.R.A.C}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
A(4-24)(F23A)H2
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|